Pain Relieving Cream Recalled Due to Out-of-Specification Active Ingredient
ARG Laboratories' Natural Pain Relieving Cream Golden Tiger is being recalled due to out-of-specification active ingredient and improper-grade propylene glycol used in manufacturing. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The use of an improper grade of propylene glycol in a topical skin product represents a risk-of-harm situation where injury has not yet been reported.
Plain-English summary
ARG Laboratories, Inc. is recalling Natural Pain Relieving Cream, Golden Tiger brand. The product, containing Camphor 3%, Menthol 3%, Capsaicin, Aloe Vera, Willow Bark, and MSM, is sold in 128 fl. oz. (3776 ml) gallon jugs and distributed nationwide.
The recall was issued due to out-of-specification active ingredient levels. A violative grade of propylene glycol was used during the manufacturing process.
The affected product is Lot Number 01823C2 with expiration date 01/31/2025. Consumers should discontinue use of this product. No illnesses or injuries have been reported.
Consumers with questions may contact ARG Laboratories, Inc. Anyone who has used the product and experiences adverse health effects should consult a healthcare provider.
The recalled product
- Product
- NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%) Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Gallon Jug 128 fl. oz. (3776 ml), Manufactured for Golden Tiger LLC, Made in USA, UPC 1 82294 00005 5
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Topical Pain Reliever
- Hazard
- out-of-spec
- propylene-glycol
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 01823C2
- Exp 01/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01